Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05246202 · ClinicalTrials.gov registry record · NA
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
A NA study of Anxiety and Alcohol Abuse, sponsored by University of Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05246202: Recruiting NA study of Anxiety and Alcohol Abuse, sponsored by University of Houston.
NCT05246202 is a NA study of Anxiety and Alcohol Abuse that is actively recruiting participants, run by University of Houston. The registered enrollment target is 250 participants, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05246202, a NA study of Anxiety and Alcohol Abuse, is actively recruiting participants, sponsored by University of Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop, evaluate the acceptability/feasibility (Phase IA), and test (Phase IB) the effectiveness of a brief, integrated, single-session, computer-based, culturally adapted personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with anxiety.
Conditions Studied
Interventions
- BEHAVIORAL Alcohol-Anxiety Personalized Feedback Intervention 2.0
- BEHAVIORAL Control Personalized Feedback Intervention
Study Locations (1)
Texas
- RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT05246202 shows while recruiting
NCT05246202 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (43% lower).
The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Alcohol-Anxiety Personalized Feedback Intervention 2.0 is the first listed.
NCT05246202 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05246202 about?
NCT05246202 is a clinical study titled "Personalized Feedback Intervention for Latinx Drinkers With Anxiety". The purpose of this study is to develop, evaluate the acceptability/feasibility (Phase IA), and test (Phase IB) the effectiveness of a brief, integrated, single-session, computer-based, culturally adapted personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiet...
What is the current status of trial NCT05246202?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2022-09-30. Estimated completion is 2026-05-31.
What conditions does trial NCT05246202 study?
This clinical trial studies the following conditions: Anxiety, Alcohol Abuse.
What interventions are being tested in trial NCT05246202?
The interventions under investigation include: Alcohol-Anxiety Personalized Feedback Intervention 2.0 (BEHAVIORAL), Control Personalized Feedback Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05246202?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05246202 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05246202's enrollment target sits among peer trials
250 68th of 364 higher than 296 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI